Tag: MAO Inhibitor

January 8, 2026 / Mohammed looti

IPRONIAZID

IPRONIAZID: A FOUNDATIONAL AGENT IN PSYCHOPHARMACOLOGY AND A HISTORICAL ANTI-TUBERCULOSIS DRUG The compound Iproniazid, chemically known as N′-isopropyl-isonicotinoylhydrazine, holds a unique and critical position in the history of medicine, serving initially as a derivative in the fight against tuberculosis (TB), but ultimately pioneering the field of biological psychiatry. Its discovery of potent psychoactive effects—specifically mood […]

Read More
October 8, 2025 / Mohammed looti

ELDEPRYL

Eldepryl: A Review of its Pharmacokinetics and Therapeutic Uses Abstract Eldepryl (selegiline hydrochloride) is a monoamine oxidase inhibitor (MAOI) used to treat symptoms of Parkinson’s disease, such as muscle rigidity, tremors, and slow movement. It is also used for depression and dementia. This review explores the pharmacokinetics and therapeutic uses of Eldepryl. Results of pharmacokinetic […]

Read More